GLP‐1 receptor agonists for Parkinson's disease

This review (2 studies; n=107) found low‐ or very low‐certainty evidence suggesting that exenatide may improve motor impairment, which may persist for some time following cessation, raising the possibility that it may have a disease‐modifying effect.

Cochrane Database of Systematic Reviews